Annual cost reductions in hypothetical scenarios 1 and 2 between 2020 and 2060
| Country | Scenario 1: reduction in projected overweight and obesity prevalence by 5% | Scenario 2: keeping overweight and obesity prevalence among men, women, boys and girls at 2019 levels through 2060 | |||
| Average annual cost reduction (billions of 2019 US$) | Percentage cost reduction (%) | Average annual cost reduction (billions of 2019 US$) | Percentage cost reduction (%) | Average annual reduction in total obesity prevalence from baseline (%) (compared with baseline projection scenario) | |
| Australia | 2.42 | 4.61 | 5.47 | 8.42 | 9.39 |
| Brazil | 3.83 | 4.35 | 11.21 | 10.12 | 12.98 |
| India | 11.88 | 9.77 | 58.44 | 28.91 | 18.11 |
| Mexico | 2.56 | 3.76 | 6.46 | 7.22 | 10.98 |
| Saudi Arabia | 1.21 | 3.58 | 3.50 | 8.32 | 14.43 |
| South Africa | 0.56 | 4.24 | 1.82 | 11.21 | 13.24 |
| Spain | 2.13 | 5.21 | 3.81 | 8.27 | 8.52 |
| Thailand | 1.57 | 5.92 | 9.32 | 23.00 | 22.26 |